Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Fauser, AA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 80 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Schilz, AJ; Kuhlcke, K; Fauser, AA; Eckert, HG
      Optimization of retroviral vector generation for clinical application

      JOURNAL OF GENE MEDICINE
    2. Roemer, E; Blau, IW; Basara, N; Kiehl, MG; Bischoff, M; Gunzelmann, S; Kirsten, D; Sanchez, H; Wocker, EL; Fauser, AA
      Toxoplasmosis, a severe complication in allogeneic hematopoietic stem celltransplantation: Successful treatment strategies during a 5-year single-center experience

      CLINICAL INFECTIOUS DISEASES
    3. Basara, N; Kiehl, MG; Fauser, AA
      New therapeutic modalities in the treatment of graft-versus-host disease

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    4. Knipper, R; Kuehlcke, K; Schiedlmeier, B; Hildinger, M; Lindemann, C; Schilz, AJ; Fauser, AA; Fruehauf, S; Zeller, WJ; Ostertag, W; Eckert, HG; Baum, C
      Improved post-transcriptional processing of an MDR1 retrovirus elevates expression of multidrug resistance in primary human hematopoietic cells

      GENE THERAPY
    5. Hartert, A; Willenbacher, W; Gunzelmann, S; Roemer, E; Basara, N; Fauser, AA; Kiehl, MG
      Successful treatment of thrombocytopenia and hemolytic anemia with IvIG ina patient with lupus-like syndrome after mismatched related PBSCT

      BONE MARROW TRANSPLANTATION
    6. Blau, IAW; Basara, N; Lentini, G; Guenzelmann, S; Kirsten, D; Schmetzer, B; Bischoff, M; Roemer, E; Kiehl, MG; Fauser, AA
      Feasibility and safety of peripheral blood stem cell transplantation from unrelated donors: results of a single-center study

      BONE MARROW TRANSPLANTATION
    7. Basara, N; Kiehl, MG; Blau, W; Romer, E; Bischoff, M; Schmetzer, B; Kirsten, D; Gunzelmann, S; Fauser, AA
      Mycophenolate mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: Four years of experience

      TRANSPLANTATION PROCEEDINGS
    8. Basara, N; Gunzelmann, S; Willenbacher, W; Fauser, AA; Kiehl, MG
      New immunosuppressants in BMT/GVHD

      TRANSPLANTATION PROCEEDINGS
    9. Grothaus-Pinke, B; Gunzelmann, S; Fauser, AA; Kiehl, MG
      Factor XIII replacement in stem cell transplant (SCT) recipients with severe graft-versus-host disease of the bowel: Report of an initial experience

      TRANSPLANTATION
    10. Kraut, L; Fauser, AA
      Anti-emetics for cancer chemotherapy-induced emesis - Potential of alternative delivery systems

      DRUGS
    11. Willenbacher, W; Basara, N; Blau, IW; Fauser, AA; Kiehl, MG
      Treatment of steroid refractory acute and chronic graft-versus-host disease with daclizumab

      BRITISH JOURNAL OF HAEMATOLOGY
    12. Remberger, M; Ringden, O; Blau, IW; Ottinger, H; Kremens, B; Kiehl, MG; Aschan, J; Beelen, DW; Basara, N; Kumlien, G; Fauser, AA; Runde, V
      No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors

      BLOOD
    13. Schilz, AJ; Schiedlmeier, B; Kuhlcke, K; Fruehauf, S; Lindemann, C; Zeller, WJ; Grez, M; Fauser, AA; Baum, C; Eckert, HG
      MDR1 gene expression in NOD/SCID repopulating cells after retroviral gene transfer under clinically relevant conditions

      MOLECULAR THERAPY
    14. Fauser, AA; Pizzocaro, G; Schueller, J; Khayat, D; Wilkinson, P
      A double-blind, randomised, parallel study comparing intravenous dolasetron plus dexamethasone and intravenous dolasetron alone for the management offractionated cisplatin-related nausea and vomiting

      SUPPORTIVE CARE IN CANCER
    15. Blau, IW; Fauser, AA
      Review of comparative studies between conventional and liposomal amphotericin B (Ambisome (R)) in neutropenic patients with fever of unknown origin and patients with systemic mycosis

      MYCOSES
    16. Basara, N; Blau, WI; Kiehl, MG; Schmetzer, B; Bischoff, M; Kirsten, D; Gunzelmann, S; Fauser, AA
      Mycophenolate mofetil for the prophylaxis of acute GVHD in HLA-mismatched bone marrow transplant patients

      CLINICAL TRANSPLANTATION
    17. Basara, N; Fauser, AA
      Safety profile of mycophenolate mofetil

      BONE MARROW TRANSPLANTATION
    18. Basara, N; Schmetzer, B; Blau, IW; Bischoff, M; Gunzelmann, S; Kirsten, D; Fauser, AA
      Lenograstim-mobilized peripheral blood progenitor cells in volunteer donors: an open label randomized split dose escalating study

      BONE MARROW TRANSPLANTATION
    19. Blau, IW; Basara, N; Bischoff, M; Gunzelmann, S; Romer, E; Kirsten, D; Schmetzer, B; Kiehl, MG; Fauser, AA
      Second allogeneic hematopoietic stem cell transplantation as treatment forleukemia relapsing following a first transplant

      BONE MARROW TRANSPLANTATION
    20. Fauser, AA; Kiehl, MG
      2nd International Symposium on Transplantation & Gene Therapy - October 21-23, 1999 - Idar-Oberstein, Germany - Preface

      BONE MARROW TRANSPLANTATION
    21. Ringden, O; Remberger, M; Runde, V; Bornhauser, M; Blau, IW; Basara, N; Holig, K; Beelen, DW; Hagglund, B; Basu, O; Ehninger, G; Fauser, AA
      Faster engraftment of neutrophils and platelets with peripheral blood stemcells from unrelated donors: a comparison with marrow transplantation

      BONE MARROW TRANSPLANTATION
    22. Basara, N; Blau, IW; Willenbacher, W; Kiehl, MG; Fauser, AA
      New strategies in the treatment of graft-versus-host disease

      BONE MARROW TRANSPLANTATION
    23. Kiehl, MG; Shipkova, M; Basara, N; Blau, WI; Fauser, AA
      New strategies in GVHD prophylaxis

      BONE MARROW TRANSPLANTATION
    24. Fauser, AA; Basara, N; Blau, IW; Kiehl, MG
      A comparative study of peripheral blood stem cell vs bone marrow transplantation from unrelated donors (MUD): a single center study

      BONE MARROW TRANSPLANTATION
    25. Kuhlcke, K; Ayuk, FA; Li, Z; Lindemann, C; Schilz, A; Schade, UM; Fauser, AA; Zander, AR; Eckert, HG; Fehse, B
      Retroviral transduction of T lymphocytes for suicide gene therapy in allogeneic stem cell transplantation

      BONE MARROW TRANSPLANTATION
    26. Eckert, HG; Kuhlcke, K; Schilz, AJ; Lindemann, C; Basara, N; Fauser, AA; Baum, C
      Clinical scale production of an improved retroviral vector expressing the human multidrug resistance 1 gene (MDR1)

      BONE MARROW TRANSPLANTATION
    27. Kiehl, MG; Shipkova, M; Basara, N; Blau, IW; Schutz, E; Armstrong, VW; Oellerich, M; Fauser, AA
      Mycophenolate mofetil in stem cell transplant patients in relation to plasma level of active metabolite

      CLINICAL BIOCHEMISTRY
    28. Fauser, AA; Fellhauer, M; Hoffmann, M; Link, H; Schlimok, G; Gralla, RJ
      Guidelines for anti-emetic therapy: Acute emesis

      EUROPEAN JOURNAL OF CANCER
    29. Fauser, AA; Dornoff, W; Briese, V; Knutzen, B; Herzog, G; Schultze, W; Nowicki, J
      The anti-emetic efficacy of intravenous dolasetron mesilate plus dexamethasone versus intravenous dolasetron mesilate alone in patients receiving fractionated chemotherapy

      ONKOLOGIE
    30. Basara, N; Jelkmann, W; Schmetzer, B; Gunzelmann, S; Bischoff, M; Blau, WI; Kiehl, MG; Fauser, AA
      Plasma thrombopoietin level in patients receiving unrelated and related bone marrow and blood stem cell transplants

      THROMBOSIS AND HAEMOSTASIS
    31. Hoffken, G; Pasold, R; Pfluger, KH; Finke, J; Fauser, AA; Szelenyi, H; Wagner, J
      An open, randomized, multicentre study comparing the use of low-dose ceftazidime or cefotaxime, both in combination with netilmicin, in febrile neutropenic patients

      Journal of antimicrobial chemotherapy
    32. Blau, IW; Basara, N; Serr, A; Seidl, C; Seifried, E; Fuchs, M; Bischoff, M; Roemer, E; Fauser, AA
      A second unrelated bone marrow transplant: successful quantitative monitoring of mixed chimerism using a highly discriminative PCR-STR system

      CLINICAL AND LABORATORY HAEMATOLOGY
    33. Ringden, O; Remberger, M; Runde, V; Bornhauser, M; Blau, IW; Basara, N; Holig, K; Beelen, DW; Hagglund, H; Basu, O; Ehninger, G; Fauser, AA
      Peripheral blood stem cell transplantation from unrelated donors: A comparison with marrow transplantation

      BLOOD
    34. Hehlmann, R; Hochhaus, A; Kolb, HJ; Hasford, J; Gratwohl, A; Heimpel, H; Siegert, W; Finke, J; Ehninger, G; Holler, E; Berger, U; Pfirrmann, M; Muth, A; Zander, A; Fauser, AA; Heyll, A; Nerl, C; Hossfeld, DK; Loffler, H; Pralle, H; Queisser, W; Tobler, A
      Interferon-alpha before allogeneic bone marrow transplantation in chronic myelogenous leukemia does not affect outcome adversely, provided it is discontinued at least 90 days before the procedure

      BLOOD
    35. Basara, N; Markova, J; Schmetzer, B; Blau, IW; Kiehl, MG; Bischoff, M; Kirsten, D; Fauser, AA
      Chronic eosinophilic leukemia: Successful treatment with an unrelated bonemarrow transplantation

      LEUKEMIA & LYMPHOMA
    36. BISCHOFF ME; BLAU W; WAGNER T; WAGENMANN W; DORNER O; BASARA N; FAUSER AA
      TOTAL-BODY IRRADIATION AND CYCLOPHOSPHAMIDE IS A CONDITIONING REGIMENFOR UNRELATED BONE-MARROW TRANSPLANTATION IN A PATIENT WITH CHRONIC MYELOGENOUS LEUKEMIA AND RENAL-FAILURE ON HEMODIALYSIS

      Bone marrow transplantation
    37. BASARA N; BLAU WI; ROMER E; RUDOLPHI M; BISCHOFF M; KIRSTEN D; SANCHEZ H; GUNZELMANN S; FAUSER AA
      MYCOPHENOLATE MOFETIL FOR THE TREATMENT OF ACUTE AND CHRONIC GVHD IN BONE-MARROW TRANSPLANT PATIENTS

      Bone marrow transplantation
    38. HERRMANN D; SCHMETZER B; SCHILZ A; BLAU W; ROEMER E; BISCHOFF M; KIRSTEN D; RUDOLPHI M; GUNZELMANN S; SANCHEZ H; FAUSER AA
      COLLECTION OF CORD BLOOD STEM-CELLS FOR TRANSPLANTATION

      Bone marrow transplantation
    39. BASARA N; BISCHOFF M; BLAU IW; HERMANN D; ROMER E; RUDOLPHI M; KIRSTEN D; SANCHEZ H; FAUSER AA
      A 2ND UNRELATED BONE-MARROW TRANSPLANT WITH AN UNRELATED DONOR MARROW- TREATMENT OF A PATIENT WITH RELAPSED LEUKEMIA

      Bone marrow transplantation
    40. BLAU IW; HERRMANN D; SCHMETZER B; ROEMER E; BISCHOFF M; FAUSER AA
      ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION DOES NOT INCREASE THE INCIDENCE AND SEVERITY OF ACUTE GRAFT-VERSUS-HOST DISEASE - EXPERIENCE WITH 52 FAMILY RELATED AND UNRELATED MARROW DONOR TRANSPLANTS

      Bone marrow transplantation
    41. GENGENBACHER D; GUNZELMANN S; RUDOLPHI M; BLAU W; BENDER M; SCHMETZER B; HERRMANN D; KIRSTEN D; SANCHEZ H; ROEMER E; BISCHOFF M; FAUSER AA
      GRAFT VERSUS LYMPHOMA REACTION IN STAGE-IV B-CELL NON-HODGKINS-LYMPHOMA AFTER ALLOGENEIC PERIPHERAL STEM-CELL TRANSPLANTATION AND REPEATED STEM-CELL REINFUSION

      Bone marrow transplantation
    42. ARNOLD R; BUNJES D; DEEG HJ; EINSELE H; FAUSER AA; FINKE J; HERTENSTEIN B; HEYLL A; KOLB HJ; KOLBE K; MARTIN H; NIEDERWIESER D; SCHAEFER UW; SCHMITZ N; SCHWERDTFEGER R; SIEGERT W; WANDT H; ZANDER A; GOEKBUGET N; HOELZER D
      BMT IN REFRACTORY OR RELAPSED ADULT ALL PATIENTS TREATED IN THE GERMAN MULTICENTER ALL STUDIES

      Bone marrow transplantation
    43. KIRSTEN D; BLAU IW; BASARA N; RUDOLPHI M; BISCHOFF M; ROEMER E; FAUSER AA
      ALLOGENEIC BMT PBSCT IN PATIENTS WITH RELAPSED OR REFRACTORY LEUKEMIAAND LYMPHOMA - A SINGLE INSTITUTION EXPERIENCE/

      Bone marrow transplantation
    44. ROEMER E; BLAU IW; BISCHOFF M; GUNZELMANN S; RUDOLPHI M; KIRSTEN D; FAUSER AA; KIEHL MG
      MULTIORGAN FAILURE (MOF) AS THE MOST FREQUENT CAUSE OF EARLY TRANSPLANT-RELATED MORTALITY (TRM)

      Bone marrow transplantation
    45. BASARA N; BLAU W; KIEHL MG; ROMER E; RUDOLPHI M; BISCHOFF M; KIRSTEN D; SANCHEZ H; GUNZELMANN S; FAUSER AA
      THE EFFICACY AND SAFETY OF MYCOPHENOLATE MOFETIL (MMF) IN THE TREATMENT OF ACUTE AND CHRONIC GVHD IN BONE-MARROW TRANSPLANT PATIENTS

      Bone marrow transplantation
    46. RUDOLPHI M; BLAU IW; ROMER E; BISCHOFF M; FAUSER AA; KIEHL MG
      DIAGNOSTIC YIELD OF BRONCHOALVEOLAR LAVAGE (BAL) AND TRANSBRONCHIAL BIOPSY (TBB) IN PATIENTS AFTER ALLOGENEIC BRIT

      Bone marrow transplantation
    47. ROEMER E; BLAU IW; BISCHOFF M; GUNZELMANN S; SANCHEZ H; RUDOLPHI M; KIRSTEN B; GENGENBACHER D; FAUSER AA
      SUCCESSFUL TREATMENT OF CEREBRAL TOXOPLASMOSIS FOLLOWING ALLOGENEIC BMT PBSCT/

      Bone marrow transplantation
    48. RUDOLPHI M; BASARA N; FAUSER AA; BLAU IW
      SEVERE COMPLICATION AFTER ALLOGENEIC BMT - PNEUMOTHORAX AND MEDIASTINAL EMPHYSEMA IN A PATIENT WITH BOOP (BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA)

      Bone marrow transplantation
    49. RUDOLPHI M; ROMER E; BISCHOFF M; KIRSTEN D; GUNZELMANN S; KIEHL MG; BLAU IW; FAUSER AA
      BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA (BOOP) AFTER ALLOGENEICBONE-MARROW TRANSPLANTATION (BMT)

      Bone marrow transplantation
    50. GENGENBACHER D; GUENZELMANN S; SCHMETZER B; ROMANAKIS K; BENDER M; BISCHOFF M; FAUSER AA
      MONITORING OF GRAFT FUNCTION AND RESIDUAL LEUKEMIA BY CELL-CYCLE KINETICS AND DRUG-RESISTANCE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Bone marrow transplantation
    51. RICHTER E; EICHLER H; RASKE D; HERRMANN D; BLAU W; KEROWGAN M; FAUSER AA; GOLDMANN SF
      PERIPHERAL-BLOOD STEM-CELL MOBILIZATION BY G-CSF IN RELATED DONORS

      Bone marrow transplantation
    52. SCHILZ AJ; BROUNS G; KNOSS H; OTTMANN O; HOELZER D; FAUSER AA; THRASHER A; GREZ M
      EFFICIENT GENE-TRANSFER TO HUMAN REPOPULATING CELLS

      Molecular immunology
    53. Basara, N; Blau, WI; Kiehl, MG; Romer, E; Rudolphi, M; Bischoff, M; Kirsten, D; Sanchez, H; Gunzelmann, S; Fauser, AA
      Efficacy and safety of mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant recipient

      TRANSPLANTATION PROCEEDINGS
    54. GENGENBACHER DM; ROMANAKIS K; KNIPPER R; SCHMETZER B; BENDER M; FAUSER AA
      IMPACT OF CELL-CYCLE ANALYSIS AND DRUG-RESISTANCE FOR MONITORING AND FOLLOW-UP OF HEMATOLOGIC MALIGNANCIES

      British Journal of Haematology
    55. SCHILZ AJ; BROUNS G; KNOSS H; OTTMANN OG; HOELZER D; FAUSER AA; THRASHER AJ; GREZ M
      HIGH-EFFICIENCY GENE-TRANSFER TO HUMAN HEMATOPOIETIC SCID-REPOPULATING CELLS UNDER SERUM-FREE CONDITIONS

      Blood
    56. FAUSER AA; RUSS W; BISCHOFF M
      ORAL DOLASETRON MESILATE (MDL-73,147EF) FOR THE CONTROL OF EMESIS DURING FRACTIONATED TOTAL-BODY IRRADIATION AND HIGH-DOSE CYCLOPHOSPHAMIDEIN PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Supportive care in cancer
    57. BASARA N; BLAU W; ROMER E; RUDOLPHI M; BISHOFF M; KIRSTEN D; SANCHEZ H; GUNZELMANN S; FAUSER AA
      MYCOPHENOLATE MOFETIL (MMF) FOR THE TREATMENT OF ACUTE AND CHRONIC GVHD IN BONE-MARROW TRANSPLANT PATIENTS

      Experimental hematology
    58. GENGENBACHER DM; BLAU IW; ROEMER E; RUDOLPHI M; BISCHOFF M; KIRSTEN D; SANCHEZ H; GUENZELMANN S; THIELE B; FAUSER AA
      IMPACT OF HLA-MISMATCH FOR GRAFT-VERSUS-HOST DISEASE AND CHIMERISM INUNRELATED BONE-MARROW TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME

      Human immunology
    59. GENGENBACHER DM; ROMANAKIS R; SCHMETZER B; GUENZELMANN S; BENDER M; HERRMANN D; BLAU IW; BISCHOFF M; SANCHEZ H; ROEMER E; THIELE B; RUDOLPHI M; KIRSTEN D; FAUSER AA
      CLINICAL-SIGNIFICANCE OF DRUG-RESISTANCE AND CELL-CYCLE ANALYSIS IN ACUTE-LEUKEMIA DURING CHEMOTHERAPY AND ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Blood
    60. BLAU IW; HERRMANN D; SCHMETZER B; GENGENBACHER DM; BISCHOFF M; BASARA N; FAUSER AA
      ANALYSIS OF THE INCIDENCE AND SEVERITY OF ACUTE GRAFT-VERSUS-HOST DISEASE IN PATIENTS UNDERGOING ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION - A SINGLE INSTITUTION OF 55 FAMILY RELATED AND UNRELATED MARROW DONOR TRANSPLANTS

      Blood
    61. RUDOLPHI M; BASARA N; BISCHOFF M; BLAU IW; GENGENBACHER DM; GUNZELMANN S; SCHMETZER B; HERRMANN D; ROMER E; KIRSTEN D; SANCHEZ H; FAUSER AA
      INDUCTION OF GRAFT VERSUS LYMPHOMA REACTION IN STAGE IV B-CELL NON-HODGKINS-LYMPHOMA AFTER ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANT- COMPARISON OF LABORATORY, RADIOLOGICAL AND CLINICAL FINDINGS

      Blood
    62. GENGENBACHER DM; BISCHOFF M; GUENZELMANN S; ROEMER E; KIRSTEN D; RUDOLPHI M; SANCHEZ H; BASARA N; BLAU IW; FAUSER AA
      MATCHED UNRELATED AND RELATED BONE-MARROW TRANSPLANTATION FOR HIGH-RISK MYELODYSPLASTIC SYNDROME AND SECONDARY ACUTE MYELOID-LEUKEMIA

      Blood
    63. KIRSTEN D; BLAU IW; BASARA N; BISCHOFF M; GENGENBACHER D; FAUSER AA
      ANALYSIS OF TRANSPLANTATION RELATED MORTALITY (TRM) OF 65 PATIENTS ATHIGH-RISK RECEIVING A MUD BONE-MARROW AND OR A PERIPHERAL STEM-CELL TRANSPLANT - A SINGLE INSTITUTION EXPERIENCE/

      Blood
    64. BASARA N; BLAU W; ROMER E; RUDOLPHI M; BISCHOFF M; KIRSTEN D; SANCHEZ H; GUNZELMANN S; FAUSER AA
      MYCOPHENOLATE MOFETIL FOR THE TREATMENT OF ACUTE AND CHRONIC GVHD IN BONE-MARROW TRANSPLANT PATIENTS

      Blood
    65. FAUSER AA; DUCLOS B; CHEMAISSANI A; DELFAVERO A; COGNETTI F; DIAZRUBIO E; CORTESFUNES H; CONTE PF; DRESSLER H
      THERAPEUTIC EQUIVALENCE OF SINGLE ORAL DOSES OF DOLASETRON MESILATE AND MULTIPLE DOSES OF ONDANSETRON FOR THE PREVENTION OF EMESIS AFTER MODERATELY EMETOGENIC CHEMOTHERAPY

      European journal of cancer
    66. BLAU IW; FAUSER AA
      ANTIFUNGAL PROPHYLAXIS IN NEUTROPENIC CAN CER-PATIENTS AND ALLOGENEICBONE-MARROW TRANSPLANTATION

      Mycoses
    67. FAUSER AA; BLEIBERG H; CHEVALLIER B; FAVRE R; FABBRO M; NOBLE A; CUPISSOL D; DEGARDIN M; CAPPELAERE P; SPAETH D; CLAVERIE N
      A DOUBLE-BLIND, RANDOMIZED, PARALLEL STUDY OF IV DOLASETRON MESILATE VERSUS IV METOCLOPRAMIDE IN PATIENTS RECEIVING MODERATELY EMETOGENIC CHEMOTHERAPY

      The Cancer journal
    68. BLAU IW; SERR A; SCHILZ A; SCHMETZER B; HERRMANN D; BENDER M; BISCHOFF M; ROEMER E; FAUSER AA
      CLINICAL-RESULTS OF BONE-MARROW TRANSPLANTATION IN COMBINATION WITH CD34(-BLOOD STEM-CELLS IN HIGH-RISK PATIENTS WITH LEUKEMIA() SELECTED PERIPHERAL)

      Experimental hematology
    69. FAUSER AA; BERGERAT JP; COCQUYT V; CHEMAISSANI A; DELFAVERO A; DRESSLER HT
      DOUBLE-BLIND, COMPARATIVE TRIAL OF 4 SINGLE ORAL DOSES OF DOLASETRON MESILATE (DM) AND MULTIPLE DOSES OF ONDANSETRON (OND) FOR EMESIS PREVENTION AFTER MODERATELY EMETOGENIC CHEMOTHERAPY (CT)

      European journal of cancer
    70. VONLAER D; MEYERKOENIG U; SERR A; FINKE J; FAUSER AA; NEUMANNHAEFELIN D; BRUGGER W; HUFERT FT
      DETECTION OF CYTOMEGALOVIRUS DNA IN CD34+ HEMATOPOIETIC PROGENITOR CELLS

      Experimental hematology
    71. SCHMITZ N; DREGER P; ZANDER AR; EHNINGER G; WANDT H; FAUSER AA; KOLB HJ; ZUMSPREKEL A; MARTIN A; HECHT T
      RESULTS OF A RANDOMIZED, CONTROLLED, MULTICENTER STUDY OF RECOMBINANTHUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (FILGRASTIM) IN PATIENTS WITH HODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA UNDERGOING AUTOLOGOUS BONE-MARROW TRANSPLANTATION

      Bone marrow transplantation
    72. VONLAER D; MEYERKOENIG U; SERR A; FINKE J; KANZ L; FAUSER AA; NEUMANNHAEFELIN D; BRUGGER W; HUFERT FT
      DETECTION OF CYTOMEGALOVIRUS DNA IN CD34(-MARROW() CELLS FROM BLOOD AND BONE)

      Blood
    73. KREISEL W; HERBST EW; SCHWIND B; OCHS A; OLSCHEWSKI M; KOCHLING G; FAUSER AA
      DIAGNOSIS AND GRADING OF ACUTE GRAFT-VERSUS-HOST DISEASE FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION BY SIGMOIDOSCOPY

      European journal of gastroenterology & hepatology
    74. FAUSER AA; LANG E; KOCHLING G; DASCHNER FD
      A RANDOMIZED CLINICAL-TRIAL OF CEFTRIAXONE AND TEICOPLANIN VERSUS CEFTAZIDIME AND TEICOPLANIN AS ANTIBIOTIC-THERAPY IN FEBRILE NEUTROPENIC CANCER-PATIENTS AND BONE-MARROW TRANSPLANT RECIPIENTS

      Infection
    75. CONROY T; CAPPELAERE P; FABBRO M; FAUSER AA; SPLINTER TAW; SPIELMANN M; SCHNEIDER M; CHEVALLIER B; GOUPIL A; CHAUVERGNE J; FARGEOT P; PREVOT G; OGRADY P; GREEN D; HARDENBERG J; BOYCE M
      ACUTE ANTIEMETIC EFFICACY AND SAFETY OF DOLASETRON MESYLATE, A 5-HT3 ANTAGONISTS, IN CANCER-PATIENTS TREATED WITH CISPLATIN

      American journal of clinical oncology
    76. FINKE J; EUCHENHOFER B; ZELLER C; HEINZ J; SCHREINER T; MERTELSMANN R; FAUSER AA
      SUCCESSFUL ALLOGENIC TRANSPLANTATION AFTER AUTOLOGOUS GRAFT FAILURE

      Transplantation
    77. KREISEL W; HERBST EW; GEROK W; FAUSER AA
      ENDOSCOPIC DIAGNOSIS AND GRADING OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Gastroenterology
    78. LINK H; BOOGAERTS MA; FAUSER AA; SLAVIN S; REIFFERS J; GORIN NC; CARELLA AM; MANDELLI F; BURDACH S; FERRANT A; LINKESCH W; TURA S; BACIGALUPO A; SCHINDEL F; HEINRICHS H
      A CONTROLLED TRIAL OF RECOMBINANT-HUMAN-ERYTHROPOIETIN AFTER BONE-MARROW TRANSPLANTATION

      Blood
    79. RINGDEN O; FAUSER AA
      GVHD - PROPHYLAXIS AND TREATMENT

      Bone marrow transplantation
    80. SCHMITZ N; DREGER P; ZANDER A; EHNINGER G; WANDT H; FAUSER AA; KOLB HJ; SUTTORP M; MARTIN A
      A RANDOMIZED, CONTROLLED, MULTICENTER STUDY OF GRANULOCYTE-COLONY-STIMULATING FACTOR (FILGRASTIM) IN PATIENTS WITH HODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA UNDERGOING AUTOLOGOUS BONE-MARROW TRANSPLANTATION

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/10/20 alle ore 05:34:21